参考文献 References
[1] Hammoudi Halat D,Ayoub Moubareck C.The current burden of carbapenemases:review of significant properties and dissemination among Gram negative bacteria[J].Antibiotics(Basel)/2020.9(4):186
[2] Porreca A M,Sullivan K V.Gallagher J C. The epidemiology evolution and treatment of KPC-Producing organisms[J].Curr infect Dis Rep,2018,20(6):13
[3] Satlin M J,Chen L,Patel G,et al. Multicenter clinical and molecular epidemiological analysis ofbacteremia due to carbapenem-resistant Enterobacteriaceae(CRE) (CRE) in the CRE Epicenter of the united States[J].Antimicrob Agents Chemother,2017,61(4)e02349-16
[4] World Health Organization. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriacea , Acine to bacteria baumannii and Pseudomonas aeruginosa in health care facilities.(2017-11)[2019-02-13].
https://www.who.int/infection-prevention/publications/guidelines-CRKP/en/.
[5] Gysin DV,Cookso B,Saenz H,et al.Variability in contactprecautions to control the nosocomial spread of multi-drug resistant organisms in the endemic setting:a multinational cross-sectional survey.Antimicrob Resist Infect Control,2018,7:81.21
[6] Liu L,Feng Y,Tang G, et al. Carbapenem-resistant isolates of the Klebsiella pneumoniae complex in Western China: the common ST11 and the surprising hospital-specific types ClinInfect Dis, 2018, 67(suppl_2): S263-S265. 26
[7] Shu LB, Lu Q, Sun RH, t al. Prevalence and phenotypic characterization of carbapenem-resistant Klebsiella pneumonia strains recovered from sputum and fecal samples of ICU patients in Zhejiang Province, China.Infect Drug Resist,2018,12:11-18.
[8] Dehmer GJ, Drozda JP Jr,Brindis RG,et al. Public reporting of clinical quality data:an updatefor cardiovascular specialists[J].J AmColl Cardiol,2014, 63(13):1239-1245.DOI:10.1016/ j.jacc.2013.11.050.
[9] Passaretti C L, Barclay P, Pronovost P, et al. Public reporting of health care-associated infections(HCAIs)：approach to choosing HCAI measures[J].Infect control Hosp Epidemiol,2011,32(8):768-774
[10] Box GE,Jenkins GM,Reinsel GC,etal.Time series analysis: forecasting and control[M].JohnWiley & Sons, 2015.
[11] Feng C, Li J, Sun W, et al. Impact of ambient fine particulate matter (PM2.5) exposure on the risk of in fluenza-like-illness: a time-series analysis in Beijing, China[J]. Environ Health, 2016,15:17.
[12] Wang T, Liu J, Zhou Y, et al. Prevalence of hemorrhagic fever with renal syndrome in Yiyuan County, China, 2005-2014[J]. BMC Infect Dis, 2016, 16: 69.
[13] Song X, Xiao J, Deng J, et al. Time series analysis of influenza incidence in Chinese provinces from 2004 to 2011[J]. Medicine (Baltimore), 2016, 95(26): e3929.
[14] Tomczyk S, Zanichelli V, Grayson ML,et al. Control of Carbapenem-resistant Enterobacteriaceae,Acinetobacter baumannii, and Pseudomonas aeruginosa in Healthcare Facilities:A Systematic Review and Reanalysis of Quasi-experimental Studies. Clin Infect Dis.2019 Feb15; 68(5):873-884.
[15] van Loon k,voor in holt AF,Vos MC.a systematic review and meta-analyses of the clinical epidemiology of carbapenem-resistant Enterobacterianceae[J].Antimicrob Agents chemother,2018,62:e01730-17
[16] Daikos G L,T saousi S,Tzouvelekis LS,et al. Carbapenemase producing blood stream infections: lowering mortality antibiotic combination schemes and the role of carbapenems[J].Antimicrob Agents chemother,2014,58(4):2322-2328
[17] Chea N, Bulens SN, Kongphet-Tran T, et al. Improved phenotype-based definition for identifying carbapenemase producers among CRE. Emerg Infect Dis 2015; 21:1611-6.
[18] Hayden MK, Lin MY, Lolans K, et al. Prevention of colonization and infection by KPC-producing Enter bacteriaceae in long term acute-care hospitals. Clin Infect Dis 2015;60:1153-61.